Background-Infarct heterogeneity has been shown to be independently associated with adverse outcomes in previous smaller studies. However, it is unknown whether infarct characterization is an independent predictor of all-cause mortality in patients with advanced ischemic cardiomyopathy, after adjusting for clinical risk factors, severity of ischemic mitral regurgitation, incomplete revascularization, and device therapy. Methods and Results-A total of 362 patients with ischemic cardiomyopathy (left ventricular dysfunction with >70% stenosis in ≥1 epicardial coronary artery) underwent delayed hyperenhancement-magnetic resonance imaging and coronary angiography between 2002 and 2006. Total myocardial scar and peri-infarct (PI) area were measured using various threshold techniques. Multivariate survival analysis (primary end point of all-cause mortality) was conducted. One hundred fiftyseven deaths occurred during a mean 5.4-year follow-up (mean left ventricular ejection fraction, 23±9%; mean end-systolic volume index, 113±48 mL; mean total myocardial scar %, 25.5±16.0%; mean PI%, 5.7±2.9%). PI% (β=2.07; P<0.001) was an independent predictor of survival, independent of age, end-systolic volume, sex, mitral regurgitation, diabetes mellitus, dyslipidemia, coronary artery disease severity, implantable cardioverter defibrillator, and incomplete revascularization. PI% using 2 to 3 SD technique yielded the highest incremental prognostic power (χ 2 score 149). Conclusions-In advanced ischemic cardiomyopathy, PI% is a powerful independent and incremental predictor of all-cause mortality. Infarct heterogeneity offers substantial further risk stratification when compared with quantification of total myocardial scar % alone even after adjusting for clinical risk factors, end-systolic volume index, mitral regurgitation, incomplete revascularization, and implantable cardioverter defibrillator implantation. (Circ Cardiovasc Imaging. 2014;7:796-804.)
D elayed hyperenhancement assessment with cardiac MRI (DHE-MRI) has emerged as a powerful prognostic tool in the assessment of patients with coronary artery disease. Quantification of myocardial infarct size assessed by DHE-MRI has been shown to be a powerful independent predictor of mortality in patients with ischemic cardiomyopathy (ICM). [1] [2] [3] Quantification of the peri-infarct (PI) border zone has also been shown to be independently associated with adverse outcomes. [4] [5] [6] [7] [8] Although previous clinical studies have demonstrated the prognostic importance of PI, these studies were relatively small, thus prohibiting the ability for robust multivariable analysis to test the independent significance of PI against important clinical variables, subsequent revascularization, and implantable cardioverter defibrillator (ICD) implantation. In addition, because these previous studies used differing threshold techniques for the quantification of infarct heterogeneity, we sought to determine the optimal threshold technique for quantification of PI% and to validate the prognostic significance of infarct heterogeneity after adjusting for clinical risk factors, such as ischemic mitral regurgitation, incomplete revascularization, and device therapy, in a relatively large cohort of patients with ICM.
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Methods
Study Design
We examined 362 patients with ICM (left ventricular ejection fraction [LVEF], ≤40% with ≥70% stenosis in ≥1 epicardial coronary vessel on angiography and history of previous myocardial infarction or coronary revascularization), who were referred for myocardial viability assessment with cardiac MRI (CMR) between January 2002 and December 2006, as previously reported. 9, 10 However, the current study population differs from the previous studies, in that we restricted our current study population to patients who underwent coronary angiography within 90 days of their CMR. Patients with standard CMR contraindications were not imaged.
Clinical and demographic variables were entered prospectively into electronic medical records. Medical treatment, post-CMR coronary revascularization (either percutaneous or surgical), and ICD/cardiac resynchronization therapy implantation was recorded. Coronary angiographic data acquired within 90 days and echocardiographic data acquired within 1 month of the cardiac MRI were also recorded.
Assessment of the completeness of revascularization in patients who underwent subsequent revascularization was determined based on the integration of coronary angiography anatomy, degree of myocardial scarring within these vascular territories on cardiac MRI, and subsequent revascularization in these corresponding vascular territories. Viable vascular territories were defined as areas with ≤50% scarring based on DHE-MRI assessment, according to the 16-segment American Heart Association model, with corresponding major epicardial coronary artery stenosis ≥70% stenosis. Vascular territories with >50% scarring were considered nonviable. Viable vascular territories that were not subsequently revascularized were considered incompletely revascularized.
All-cause mortality and time of death relative to the baseline CMR (time=0) were ascertained by social security death index and was used as the primary end point. This study was approved by the institutional review board, with a waiver of individual consent.
CMR Protocol
CMR examinations were performed on 1.5-T MR scanners (Sonata and Avanto; Siemens Medical Solutions, Erlangen, Germany), using 40 to 45 mT/m maximum gradient strength and 200 T/m per second maximum slew rate with electrocardiographic gating. For assessment of global cardiac function, steady-state free precession images were acquired (slice thickness, 8-10 mm in contiguous short-axis images). LV volumes and LV ejection fraction were calculated on short-axis steady-state free precession images. DHE-CMR images were obtained in long-and short-axis orientations, ≈15 to 20 minutes after injection of 0.2 mmol/kg of Gadolinium dimeglumine, with segmented inversion-recovery gradient echo sequences for studies performed in 2002 to 2003 and phasesensitive inversion-recovery spoiled gradient echo sequences sequence for studies performed after 2003 (spatial resolution of 1.5-2.1×1.1-1.4 mm).
CMR Analysis
DHE-CMR images were analyzed using commercially available software (CMR42; Circle Cardiovascular Imaging Inc, Calgary, Canada) by an experienced CMR reader (D.H.K.). Endocardial and epicardial myocardial contours were manually delineated on both cine and DHE-CMR short-axis images. Total myocardial scar (TMS) was defined with varying signal intensity thresholds, as previously described. 11 The following signal thresholds were evaluated to identify the optimal TMS threshold for the prediction of all-cause mortality: ≥2 SD, ≥3 SD, and ≥5 SD above the mean signal of reference myocardium and full-width half maximum (FWHM) technique. The reference normal myocardium was identified manually ( Figure 1 ). Areas that were identified as scar by the software, but not deemed to be scar by the user, were excluded manually. TMS% was automatically determined as percentage of the total myocardium (infarct volume divided by total LV volume). Each study was also semiquantitatively graded, with a standard American Heart Association 16-segment model, on a 5-point scale, with 0=no DHE, 1=DHE of 1% to 25% of LV segment, 2=DHE extending to 26% to 50%, 3=DHE extending to 51% to 75%, and 4=DHE extending to 76% to 100%. CMR analysis was completely blinded from the clinical analysis.
The following signal thresholds were evaluated to identify the optimal threshold for PI zone for the prediction of all-cause mortality, as previously described: 2 to 3 SD brighter than the remote 8 ; 2 to 5 SD brighter than the remote, 12 ≥peak signal intensity (SI) of the remote and <50% of maximal SI (peak-remote) 7 ; and FWHM technique (SI ≥35% and <50% of maximal SI). 6 As a result, core infarct (CI) areas were then designated as ≥3 SD, ≥ 5 SD, and ≥50% of the maximal SI. Total, core, and PI sizes were expressed as a percentage of the total LV mass.
Statistical Analysis
Baseline demographic data, risk factors, and clinical variables were descriptively summarized with continuous variables expressed as mean±SD and categorical data presented as percentage frequency. Spearman correlation of the different techniques for PI quantification was conducted. All-cause mortality was the primary end point. Univariable survival analysis was performed with Cox-proportional hazards analysis, and hazard ratios were generated. For forward stepwise multivariable Cox-proportional hazards analysis, we constructed multivariate model, including well-established clinical risk variables, which included variables with a P value of <0.10 on univariable survival analysis. To avoid overfitting the model, interaction terms between variables were not entered, and the number of variables entered into the model was limited to permit ≈1 variable per 10 events. 11 The incremental value of CI% and PI% over clinical data and other imaging variables was assessed by a modified stepwise procedure. The first step consisted of constructing a multivariate model of clinical and imaging data used as baseline model. Then CI% and PI% were individually added in a stepwise forward manner to the baseline model. This was repeated for each CI% and PI% threshold technique. A significant improvement in model prediction was based on the simultaneous improvement of both the log likelihood ratio statistic and χ 2 score. In addition, a clinical risk score was calculated for each patient based on parameter estimates obtained from the baseline Cox regression model. The incremental value of TMS, CI%, and PI% was then assessed by the addition of these individual variables to the Cox regression model to the overall clinical risk score. The incremental value of the added variables was based on a significant P value <0.05. Survival functions stratified by quartiles of TMS% and PI% were plotted using the Kaplan-Meier method and were compared using log-rank tests. Net reclassification index was evaluated to assess the incremental benefit of adding TMS%, CI%, and PI% to the baseline model. 13 Statistical comparisons were performed with SPSS version 20.0 (SPSS Inc, Chicago, IL) and R software version 2.12.0. A P<0.05 was considered significant. The models were carefully examined, when applicable, for proportional hazards assumption and multicollinearity.
Results
Patient Characteristics
Our population (n=362) was predominantly men (75%), with an age of 63.2±10.6 years. During a mean follow-up of 5.4±2.6 years, there were 157 deaths. The baseline characteristics are described in Table 1 . Patients were divided into 2 groups based on PI% above and below the mean (using 2-3 SD). Patients with increased PI% demonstrated a significantly higher prevalence of diabetes mellitus and hypertension, lower body surface area, and greater number of coronary arteries with significant obstruction when compared with the patients with smaller PI%. There was no statistical difference between the 2 groups in regards to age, sex, history of previous revascularization, hypertension, or medical therapy. In regards to post-MRI therapy, 235 patients underwent subsequent revascularization, whereas 127 patients were medically treated. 
CMR Findings
The mean LVEF and LV end-systolic volume index (LVESVi) in the entire population were 23±9% and 113±45, respectively ( Table 2 ). The mean TMS%, using ≥2 SD, ≥3 SD, and ≥5 SD, and FWHM techniques are as follows: 25.5±16.0%, 19.8±14.7%, 13.0±12.3%, and 17.5±11.1%, respectively. The mean PI% using 2 to 3 SD, 2 to 5 SD, peak/remote, and FWHM techniques are as follows: 5.7±2.9%, 12.5±6.7%, 6.7±4.8%, and 11.7±7.0%, respectively. There was no significant difference in regards to LVEF, LVESVi, right ventricular (RV) EF, or RVESVi between the 2 groups. Patients with larger PI% were significantly more likely to have smaller body surface areas and subsequent incomplete revascularization. As expected, patients with larger TMS%, regardless of the infarct location, had significantly larger PI% when compared with those with smaller PI%. There was a significant correlation between all of the PI threshold techniques ( Table  I in the Data Supplement).
Outcome Events
During a mean follow-up of 5.4±2.6 years, there were 157 deaths. Univariate predictors of death are listed in Table 3 . Age, body surface area, sex, hypertension, diabetes mellitus, hyperlipidemia, severity of coronary artery disease, ICD implantation, and subsequent incomplete revascularization were clinical variables, which were significantly associated with mortality. LVESVi, RVEF, RVESVi, and mitral regurgitation severity (measured by echocardiography) were imaging univariate predictors of mortality. TMS% and PI% were all significant univariate predictors of mortality, regardless of which threshold technique was used. Unadjusted Kaplan-Meier survival analysis was performed for the differing threshold techniques for TMS% and PI% (Figures 2 and 3) . Patients with higher TMS% had significantly worse outcomes when compared with those with smaller TMS% (Figure 2) , regardless of which threshold technique was used. Similarly, patients with higher PI% had worse outcomes when compared with those with smaller PI% (Figure 3) , regardless of which threshold technique was used. However, the greatest difference in survival among the quartiles of PI% was seen using the threshold techniques 2 to 3 SD and 2 to 5 SD.
A baseline multivariable Cox proportional hazard model, without TMS%, CI%, or PI%, was first constructed by entering significant covariates based on univariate analysis (Table 4 ). Cox-proportional hazards multivariate modeling identified age, female sex, RVESVi, ischemic mitral regurgitation, ICD implantation, coronary artery disease severity, and subsequent incomplete revascularizationas independent predictors of mortality. TMS% was added to this model and emerged as a powerful independent and incremental predictor of all-cause mortality ( Table 5 ). TMS% was then removed and infarct characterization defined by CI% and PI% was then added into the model (Table 6 ). Infarct heterogeneity resulted in a significant increase in χ 2 score, demonstrating substantial improvement in the goodness of fit of the multivariable model over TMS% alone. The PI% threshold of 2 to 3 SD resulted in the highest increase in χ 2 score and negative log likelihood ratio ( Figure I in the Data Supplement), demonstrating the largest incremental increase in risk stratification of all the threshold techniques. In addition, a baseline risk score was calculated from Table 4 , and TMS% and infarct heterogeneity (CI%+PI%) were individually assessed in relation to the baseline risk score (Tables 7 and 8 ). Receiver operator curves were also constructed to determine the area under the curve for the baseline model, as well as the addition of TMS% and infarct heterogeneity (Tables I and II 
Discussion
Our results demonstrate that PI%, quantified by CMR, is a powerful independent and incremental predictor of all-cause mortality in patients with advanced ICM. Our study is the first to demonstrate that PI% provides substantial additional risk stratification, even after adjusting for ischemic MR, and incomplete revascularization. Our study indicates that although TMS% alone provides independent prognostication, further characterization and quantification of infarct heterogeneity provide more powerful and incremental prediction of all-cause mortality.
Infarct Heterogeneity and All-Cause Mortality
Identification and quantification of myocardial scar with DHE-CMR have been shown to be a powerful predictor of mortality in patients with ICM. 1, 10, 14 In addition, it has been shown to correlate with ventricular tachycardia/ventricular fibrillation, 15 and we recently demonstrated that TMS% also effectively predicts survival in patients with and without subsequent ICD implantation. 9 However, further characterization of TMS% and quantification of infarct heterogeneity have been demonstrated to have important prognostic use in previous studies. [4] [5] [6] [7] [8] 16 The study of Yan et al 8 of 144 patients demonstrated that PI% (2-3 SD) is an independent predictor of all-cause mortality and cardiovascular mortality, after adjusting for LV volumes or LVEF. Other studies used appropriate ICD therapy, inducible ventricular tachycardia, or combined end points with varying threshold techniques for the quantification of PI% to demonstrate the prognostic power of PI%. [4] [5] [6] [7] The results of these studies have supported the theory that the attenuated delayed enhancement at the border zones of infarcted myocardium represents the presence of viable myocytes interspersed within the dense collagen fibrosis, providing substrate for re-entrant circuits precipitating malignant arrhythmias. However, because all of these studies captured <30 primary events, robust multivariate analysis and adjustment for baseline clinical risk factors, severity of ischemic mitral regurgitation, and subsequent revascularization could not be conducted. The previous studies did not include important variables, such as ischemic MR, and subsequent revascularization. Therefore, the incremental value of infarct heterogeneity after adjusting for these well-validated risk factors is unknown.
To the best of our knowledge, this study represents the largest study of patients with ICM and severe LV dysfunction undergoing infarct/viability assessment with CMR. Given the large number of end points in our study, we were able to assess the prognostic power of PI after adjusting for important variables, such as severity of ischemic mitral regurgitation, and completeness of coronary revascularization after CMR assessment. Our study population had severe LV dysfunction (EF, 23±9%) and enlargement (LVESVi, 113±48) in the setting of a significant myocardial scar burden. The mortality rate was 43% during a mean follow-up of 5.4 years, reflecting the highrisk nature of our patient population. In our study, TMS% was an independent predictor of all-cause mortality, regardless of which threshold technique was used. Although TMS% offers significant independent and incremental prognostic power, characterization and quantification of infarct heterogeneity result in significant incremental improvement in risk stratification in our study population (Figure 4 ; Tables 7 and 8 ).
Our results demonstrate that PI%, quantified by CMR, is a powerful independent and incremental predictor of all-cause mortality in patients with advanced ICM, even after adjusting for clinical risk factors, LVESVi, ischemic mitral regurgitation, and incomplete revascularization. Ischemic mitral regurgitation and incomplete revascularization have been shown to be powerful and important predictors of mortality in patients with advanced cardiomyopathy. Therefore, the ability of PI% to remain a powerful independent and incremental predictor of death, even after adjusting for these variables, further demonstrates the prognostic importance of characterizing infarct heterogeneity.
Comparison of Different Threshold Techniques
Schelbert et al 17 recently demonstrated the ability of highfield DHE-CMR to identify areas of fibrous tissue interspersed with viable myocardial cells in the periphery of infarct with image resolution of 50×51×51 μm. However, this study demonstrated that as image resolution decreased, more partial volume averaging occurred, resulting in overestimation of the PI area. Therefore, systematic overestimation of PI% is likely present within all the threshold techniques. Although previous studies have demonstrated the prognostic importance of identifying PI, despite the limitation of partial volume averaging, it is unclear whether the degree of overestimation of PI varies, based on threshold technique. Therefore, the optimal threshold technique for quantifying PI% has yet to be established. Histological specimens were not available in our study; however, we think that all-cause mortality is an acceptable surrogate and clinically relevant gold standard to determine the use of quantifying PI% and for the comparison of the various PI threshold techniques. Our study suggests that PI% measured by the 2 to 3 SD provides the most substantial incremental value and independent association with all-cause mortality. Therefore, although partial volume averaging may affect the precision of PI% measurements, our study demonstrates that quantification of PI% still provides important prognostic information, which provides substantial improvement of risk stratification when compared with TMS%.
Limitations
All CMR studies were obtained on a 1.5T scanner. The size of PI may vary with field strength because higher field strength (3T) yields higher SNR and spatial resolution.
Because our patient cohort represents a patient population seen at a tertiary referral center, significant selection bias may be present. Our study cohort represents a high-risk patient population, with a relatively high mortality rate. In addition, patients with previous cardiac resynchronization therapy±ICD were excluded from this study because of contraindications for MRI; potentially further affecting selection bias. CMR findings were used to guide therapy; however, CI% and PI% were not reported to the clinicians. Because we were not able to capture the cause of death in all of the patients in our study accurately, we used allcause mortality as the primary end point. Therefore, the rate of sudden cardiac death or death caused by ventricular arrhythmias is not known. However, all-cause mortality has been shown to be a more objective, robust, and unbiased end point than cardiac mortality 18 and has been the primary outcome in the randomized clinical trials evaluating the efficacy of the ICDs. [19] [20] [21] The patients in our study did not consistently return to our institution for device interrogation at regular intervals; therefore, our study may not have captured appropriate shock therapy in patients who did not return to our institution for follow-up. Inter-and intraobserver variability have previously been published on these various threshold techniques, demonstrating the least variation with FWHM techniques. 4, 12 Improved interobserver and intraobserver variability with the FWHM technique is likely because of the integration of 2 regions of interest, a user-defined maximal signal intensity in addition to the user-defined remote myocardium. However, this technique likely demonstrated the least prognostic power in our study because it often underestimates the core-infarcted areas and overestimated the PI areas when compared with the other techniques ( Figure 1 ). In addition, the accuracy of PI% by FMHM is highly dependent on sufficient image contrast between the remote myocardium and the infarcted myocardium. Therefore, although CI% measured by FWHM is not significantly affected, PI% measured by FWHM (35%-50%) can be grossly overestimated in patients with decreased image contrast between the remote and the infarcted myocardium, especially in areas of small infarction ( Figure 5 ). The degree of contrast between infarcted and viable myocardium can vary from patient to patient because it is greatly affected by glomerular filteration rate, contrast dose (ie, 0.1 versus 0.2 mm/ kg), as well as timing of DHE imaging after contrast administration. 22 However, PI% measured by 2 to 3 SD may result in increased interobserver variability based on where the remote myocardium is defined ( Figure 6 ). However, this technique is less sensitive to decreased image contrast between the infarcted and the remote myocardium ( Figure 5 ). Therefore, the remote myocardium must be carefully defined by an experienced MR user to identify areas that are only surrounding the periphery of the infarct accurately.
Conclusions
Our results demonstrate that PI%, quantified by CMR, is a significant independent and incremental predictor of all-cause mortality in patients with advanced ICM. Although TMS% offers significant independent and incremental prognostic power, PI% provides substantial improvement in risk stratification, even after adjusting for clinical risk factors, ESVi, mitral regurgitation, subsequent incomplete revascularization, and ICD implantation. 
